跳至主要内容
临床试验/NCT04368663
NCT04368663招募中不适用

The Beneficial Effect of the Traditional Japanese Medicine, Keishi-ka-shakuyaku-daio-to(TJ-134)for Patients With Symptomatic Pneumatosis Cystoides

Showa Inan General Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Change of computed tomography (CT) findings

研究概览

简要总结

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.

详细描述

  1. Based on endoscopic finding, patients with symptomatic PCI are recruited.
  2. After enrollment, abdominal symptoms are evaluated and abdominal CT is performed.
  3. Patients were randomized in a 1:1 ratio in blocks of 4 to undergo either the traditional Japanese medicine or lactomin (control). Randomization was carried out by computer-generated random sequences.
  4. The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to(TJ-134, 7.5g/day), which consists of a mixture of a compound of peony root (6 g), cinnamon bark (4 g), jujube (4 g), glycyrrhiza (2 g), rhubarb (2 g), and ginger (1 g) or lactomin (3g/day) is administered to enrolled patients for 8 weeks.
  5. After the administration of each drug for 8 weeks, abdominal symptoms are evaluated and abdominal CT is performed again.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa

排除标准

  • patients can not take Keishi-ka-shakuyaku-daio-to(TJ-134)

研究组 & 干预措施

TJ-134 group

Active Comparator

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to(TJ-134, 7.5g/day), which consists of a mixture of a compound of peony root (6 g), cinnamon bark (4 g), jujube (4 g), glycyrrhiza (2 g), rhubarb (2 g), and ginger (1 g) is administered to enrolled patients for 8 weeks.

干预措施: Japanese traditional medicine group (Drug)

Lactomin group

Placebo Comparator

Lactomin (3g/day) is administered to enrolled patients for 8 weeks.

干预措施: Japanese traditional medicine group (Drug)

结局指标

主要结局

Change of computed tomography (CT) findings

时间窗: at enrollment and 8 weeks after the administration of TJ134

Change of the intraluminal gas pockets in the colon on CT images before and after the administration of TJ-134

次要结局

  • Bloating and abdominal pain(at enrollment and 8 weeks after the administration of TJ134)
  • Abdominal symptoms(at enrollment and 8 weeks after the administration of TJ134)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Akira Horiuchi

Chief of Digestive Disease Center

Showa Inan General Hospital

研究点 (1)

Loading locations...

相似试验